Deletion of platelet CLEC-2 decreases GPIbα-mediated integrin αIIbβ3 activation and decreases thrombosis in TTP
Bojing Shao(New York Blood Center), Lijun Xia(Oklahoma Medical Research Foundation), Yuji Kondo(Frontier Science Foundation), Karen Vanhoorelbeke(Research Institute for Chromatography), Xindi Shan(University of Florida), Junmei Chen(National University of Singapore), Christopher Hoover(Oklahoma Medical Research Foundation), Jianhua Song(Oklahoma Medical Research Foundation), James N. George(University of Oklahoma), Meixiang Zhou(Oklahoma Medical Research Foundation), J. Michael McDaniel(Oklahoma Medical Research Foundation), Samuel McGee(Oklahoma Medical Research Foundation), Wolfgang Bergmeier(University of North Carolina at Chapel Hill), Robert H. Lee(University of North Carolina at Chapel Hill), José A. López(University of Washington), Huiping Shi(Oklahoma Medical Research Foundation)
Cited by 21
Related Papers
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
|The Lancet|2008|862
AMG 531, a Thrombopoiesis-Stimulating Protein, for Chronic ITP
|New England Journal of Medicine|2006|530